APE-LM

A nearly transparent emulsion composed of ultra-pure PERFLUOROPERHYDROPHENANTHRENE emulsified in egg yolk phospholipid; improves cardiac preservation.

Also Known As:

APE-LM emulsion; perfluoroperhydrophenanthrene emulsion

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Fluorinated Hydrocarbons: 4
      - Fluorocarbons: 1209
        APE-LM: 2
Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - APE-LM: 2

Related Diseases

1.	Myocardial Ischemia (Ischemic Heart Diseases) 07/01/1994 - "We postulated that hearts preserved with APE-LM would be well oxygenated during 24-hour preservation and that reperfusion of such hearts with blood would not produce functional or metabolic evidence of myocardial ischemia. "
2.	Edema (Dropsy) 09/01/1992 - "The edema of APE-LM-preserved hearts, but not that of the other two preserved groups, was reversed during 37 degrees C reperfusion. "